Items where authors include "Dawkins, B."
![[up]](/style/images/multi_up.png)
Up a levelArticle
Dawkins, B. orcid.org/0000-0002-7038-1975, Shinkins, B., Ensor, T. et al. (2 more authors) (2024) Incorporating healthcare access and equity in economic evaluations: a scoping review of guidelines. International Journal of Technology Assessment in Health Care, 40 (1). e59. ISSN 0266-4623
Warrington, L. orcid.org/0000-0002-8389-6134, Holmes, M., Gibson, A. et al. (13 more authors) (2024) Patient and clinician perspectives of an eHealth intervention for supporting cancer treatment in the UK: mixed methods evaluation of the eRAPID randomised controlled trial. BMJ Open, 14 (11). e078283. ISSN 2044-6055
Dawkins, B. orcid.org/0000-0002-7038-1975, Absolom, K. orcid.org/0000-0002-5477-6643, Hewison, J. orcid.org/0000-0003-3026-3250 et al. (13 more authors) (2024) Cost-Effectiveness of eRAPID eHealth Intervention for Symptom Management During Chemotherapy. JCO Oncology Practice. ISSN 2688-1527
Alshreef, A. orcid.org/0000-0003-2737-1365, MacQuilkan, K., Dawkins, B. et al. (9 more authors) (2019) Cost-Effectiveness of Docetaxel and Paclitaxel for Adjuvant Treatment of Early Breast Cancer: Adaptation of a Model-Based Economic Evaluation From the United Kingdom to South Africa. Value in Health Regional Issues, 19. pp. 65-74. ISSN 2212-1099
Proceedings Paper
Dawkins, B., Gkountouras, G., Meads, D. et al. (21 more authors) (2024) Cost-Effectiveness of Frailty-Adjusted Therapy in Transplant Non-Eligible Patients with Newly Diagnosed Multiple Myeloma - an Economic Evaluation of the Fitness Trial. In: Blood. The 66th ASH Annual Meeting, 07-10 Dec 2024, San Diego, USA. American Society of Hematology , pp. 385-386.
Cook, G., Pawlyn, C., Royle, K.-L. et al. (20 more authors) (2024) IMWG Frailty Score-Adjusted Therapy Delivery Reduces the Early Mortality Risk in Newly Diagnosed Tne Multiple Myeloma: Results of the UK Myeloma Research Alliance (UK-MRA) Myeloma XIV Fitness Trial. In: Blood. The 66th ASH Annual Meeting, 07 Dec 2024, San Diego, USA. American Society of Hematology , pp. 673-674.